Arrowhead Pharmaceuticals, Inc. (ARWR)
71.31
-2.02
(-2.75%)
USD |
NASDAQ |
Jun 10, 10:49
Arrowhead Pharmaceuticals Profit Margin (Quarterly) : -186.6% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 45.29% |
| Revolution Medicines, Inc. | -- |
| Kymera Therapeutics, Inc. | -201.5% |
| ImmunityBio, Inc. | -1.43K% |
| Vera Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -47.38% |
| Return on Assets | -16.42% |
| Return on Invested Capital | -19.10% |
| Gross Profit Margin (Quarterly) | 91.36% |
| Operating Margin (Quarterly) | -191.6% |
| Return on Net Operating Assets | -54.28% |